Home
Background on "One Voice" Start here One Voice Glossary of positive language The evidence The Parker Institute
Planning the transition Planning the transition Factors for transitioning The transition path Patient letter
During transition During transition Patient archetypes Dos and don’ts Patient materials
Other transition considerations Other transition considerations Injection / infusion experience
Post transition monitoring Post transition monitoring Post transition monitoring
Contact Biogen
Shortcuts
Shortcuts
  1. Home
  2. Cookies
  • Home
  • Terms and conditions of use  |
  •  Contact Biogen  |
  •  Privacy policy |
  • Cookies

Background on "One Voice"

  • One Voice
  • Glossary of positive language
  • The evidence
  • The Parker Institute

Planning the transition

  • Factors for transitioning
  • The transition path
  • Patient letter

During transition

  • Patient archetypes
  • Dos and don’ts
  • Patient materials

Other transition considerations

  • Injection / infusion experience

Post transition monitoring

  • Post transition monitoring

This site is exclusively intended for healthcare professionals residing in the EU.
Biogen International GmbH, Neuhofstrasse 30, 6340 Baar, Switzerland.
© 2018 Biogen. All rights reserved. BIO-BBU-0026m. Date of preparation: April 2018

Enter your email address above and we’ll send you your password.

Cancel

Email containing temporary password has been sent.

You are leaving Biosimilars-RIGHT.eu.

This link will take you to a website that is outside the control of Biogen. We provide links as a public service and for informational purposes only. We do not make or imply any endorsement of external websites.

CONTINUE

You are about to leave Biosimilars-RIGHT.eu

CONTINUE

You are leaving Biosimilars-RIGHT.eu

CONTINUE